Pacira BioSciences' Operating Expenses fell 43.80% to $173.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $675.2 million, marking a year-over-year decrease of 11.14%. This contributed to the annual value of $774.3 million for FY2024, which is 31.85% up from last year.
Pacira BioSciences' Operating Expenses amounted to $173.2 million in Q3 2025, which was up 0.32% from $172.6 million recorded in Q2 2025.
In the past 5 years, Pacira BioSciences' Operating Expenses registered a high of $308.1 million during Q3 2024, and its lowest value of $96.3 million during Q3 2021.
For the 3-year period, Pacira BioSciences' Operating Expenses averaged around $170.4 million, with its median value being $162.5 million (2024).
As far as peak fluctuations go, Pacira BioSciences' Operating Expenses surged by 110.73% in 2024, and later slumped by 43.80% in 2025.
Quarterly analysis of 5 years shows Pacira BioSciences' Operating Expenses stood at $155.0 million in 2021, then grew by 17.33% to $181.8 million in 2022, then dropped by 18.57% to $148.1 million in 2023, then rose by 9.77% to $162.5 million in 2024, then plummeted by 43.80% to $173.2 million in 2025.
Its last three reported values are $173.2 million in Q3 2025, $172.6 million for Q2 2025, and $166.9 million during Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value